CENTRAL CHONDROSARCOMA, GRADE 3

Clinical trials for CENTRAL CHONDROSARCOMA, GRADE 3 explained in plain language.

Never miss a new study

Get alerted when new CENTRAL CHONDROSARCOMA, GRADE 3 trials appear

Sign up with your email to follow new studies for CENTRAL CHONDROSARCOMA, GRADE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Immune system boost tested against rare, Tough-to-Treat cancers

Disease control Ongoing

This study is testing whether a drug called atezolizumab can help control advanced forms of two rare cancers: chondrosarcoma (bone cancer) and clear cell sarcoma (soft tissue cancer). The drug works by helping the patient's own immune system recognize and attack the cancer cells.…

Matched conditions: CENTRAL CHONDROSARCOMA, GRADE 3

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

CENTRAL CHONDROSARCOMA, GRADE 3

Get alerted when new CENTRAL CHONDROSARCOMA, GRADE 3 trials appear

Immune system boost tested against rare, Tough-to-Treat cancers